| Region: | |
| Category: |
(138 reports matching your criteria)
|
Healthcare Building Construction in Tunisia to 2017: Market Databook
6/17/2013 | published by: Timetric
... (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. Summary This report is the result of Timetric’s extensive market ...
|
read more...
|
$500.00
|
|
Tanzania Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
... burden over the next two decades -limiting revenue earning opportunities for companies whose product portfolios contain medicines for thetreatment of long-term diseases. Headline Expenditure Projections Pharmaceuticals: TZS667.71bn (US$421mn) in 2012 to an anticipated TZS738.69bn (US$457mn) ...
|
read more...
|
$1,295.00
|
|
Algeria Pharmaceuticals and Healthcare Report Q3 2013
5/22/2013 | published by: Business Monitor International
... for pharmaceutical consumptiongrowth, which should also benefit from an expansion of private healthcare that is of increasing appeal tothe country’s growing middle class. However, we caution that cost-containment pressures are likely toprioritise generic and locally ...
|
read more...
|
$1,295.00
|
|
Zambia Pharmaceuticals and Healthcare Report Q3 2013
5/22/2013 | published by: Business Monitor International
... Lusaka, the population of rural communities rarelyhas access to specialist services. There are also other differences in rural/urban healthcare provision, suchas those relating to the drug supply chain, drug quality concerns and a lack of ...
|
read more...
|
$1,295.00
|
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... are many challenges to doing business inthe country, not least the presence of substandard drugs, lack of trained healthcare personnel, weak IPframework and supply chain concerns (such as a lack of suitable storage facilities in ...
|
read more...
|
$1,295.00
|
|
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... a downside risk to the future growthpotential of the pharmaceutical industry. Headline Expenditure Projections Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.38bn (US$510mn) in 2013; +24.0% inlocal currency terms with a contraction of -6.8% in US ...
|
read more...
|
$1,295.00
|
|
Herbal/Traditional Products in Tunisia
5/8/2013 | published by: Euromonitor International
... among Tunisian consumers and the limited information available about the added value of herbal/traditional products rather than standard OTC consumer health products. Euromonitor International's Herbal/Traditional Products in Tunisia report offers a comprehensive guide to the ...
|
read more...
|
$900.00
|
|
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... we project that the fullpotential of the pharmaceutical sector will only be seen if major improvements are made to Cameroon'seconomy and government contributions to healthcare. Headline Expenditure Projections Pharmaceuticals: XAF134.81bn (US$260mn) in 2012 to XAF153.17bn ...
|
read more...
|
$1,175.00
|
|
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... (US$268mn) in 2012 to NAD2.36bn (US$259mn) in 2013; +7.1% inlocal currency and -3.3% in US dollar terms. Healthcare: NAD5.08bn (US$619mn) in 2012 to NAD5.40bn (US$594mn) in 2013; +6.3% in localcurrency and -4.0% in US dollar ...
|
read more...
|
$1,175.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... should be considered by the government asa means of reducing import reliance. Evidently, it would lead to shortages in medicine supplies. However,in light of evidence that fixed capital investments may have been increasing over the ...
|
read more...
|
$1,175.00
|
|
Angola Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... growing middle class and demand for healthcare is climbing. However there areconsiderable gaps between the needs of the affluent, urban population, and those living in isolated, ruralparts of the country. The burden of disease also ...
|
read more...
|
$1,175.00
|
|
Gabon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... significant health burden over the next twodecades. This will continue to limit revenue-earning opportunities for companies whose product portfolioscontain treatments for long-term diseases. Headline Expenditure Forecasts Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF72.45bn (US$148mn) in ...
|
read more...
|
$1,175.00
|
|
Botswana Pharmaceuticals and Healthcare Report Q3 2013
5/1/2013 | published by: Business Monitor International
... improvements in various areas such as its healthcare deliveryservices, population's affluence and general improvements to its living standards before the country can seemajor investments from foreign pharmaceutical firms. Headline Expenditure Projections: Pharmaceuticals: BWP1.50bn (US$200mn) in ...
|
read more...
|
$1,175.00
|
|
Business Strategy: Necessity Breeds Opportunity: mHealth in South Africa and Lessons for MEA
4/28/2013 | published by: IDC
... While opportunities are excellent in the South African healthcare system for various mHealth and telemedicine initiatives, as they are across much of the Middle East and Africa (MEA), IDC believes greater efforts are needed to ...
|
read more...
|
$4,800.00
|
|
Kenya Pharmaceuticals and Healthcare Report Q3 2013
4/24/2013 | published by: Business Monitor International
... well as being home to the strategically important port of Mombasa. However, we caution there are weaknesses in the business environment, most notably a high level ofcorruption, which can make it difficult for both local ...
|
read more...
|
$1,175.00
|
|
Herbal/Traditional Products in Algeria
4/23/2013 | published by: Euromonitor International
... them in parallel for better and faster results. Euromonitor International's Herbal/Traditional Products in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest ...
|
read more...
|
$900.00
|
|
MoHSW - Herbal Medicine Hospital - Gambia - Construction Project Profile
4/22/2013 | published by: World Market Intelligence
... project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The MoHSW - Herbal Medicine Hospital - ...
|
read more...
|
$75.00
|
|
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... have decided not toforecast healthcare expenditure and pharmaceutical market subsector indicators, until reliable data fromglobal bodies such as the World Health Organization (WHO) become available. In the meantime, foreigndirect investment (FDI), urgently required to assist ...
|
read more...
|
$1,175.00
|
|
Morocco Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... services. However, factorssuch as the lack of qualified healthcare staff and large sections of low-income population will continue tohamper a more effective uptake of pharmaceuticals, although imports will continue to dominate. Headline Expenditure Projections Pharmaceuticals: ...
|
read more...
|
$1,175.00
|
|
South Africa Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... the Rand, should be seen as an opportunity for local drugmakers to shift focustowards increasing exports to emerging markets in order to drive long-term revenues. Although thegovernment favours local drugmakers in tender allocations, increasing generic ...
|
read more...
|
$1,175.00
|
|
Uganda Pharmaceuticals and Healthcare Report Q2 2013
4/10/2013 | published by: Business Monitor International
... burden over the next two decades -continuing to limit revenue earning opportunities for companies whose product portfolios containmedicines for the treatment of long-term diseases. Headline Expenditure Projections Pharmaceuticals: UGX830.81bn (US$330mn) in 2012 to UGX931.14bn (US$350mn) ...
|
read more...
|
$1,175.00
|
|
Ghana Pharmaceuticals and Healthcare Report Q2 2013
3/27/2013 | published by: Business Monitor International
... annual growth of pharmaceutical sales indouble-digits throughout the course of our 10-year forecast period. Key drivers behind this growth includeincreased coverage under the national health insurance scheme, growing government spending onhealthcare and improvements in healthcare ...
|
read more...
|
$1,175.00
|
|
Egypt Pharmaceuticals and Healthcare Report Q2 2013
3/13/2013 | published by: Business Monitor International
... pharmaceutical market, it is vital thatcompanies recognise the risks. Downside risks to our forecast, in addition to the country's state ofpolitical and economic flux, are: the patent cliff, pricing, higher domestic drug production output anda ...
|
read more...
|
$1,175.00
|
|
Healthcare, Regulatory and Reimbursement Landscape - Egypt
2/15/2013 | published by: GlobalData
... on Egypt’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights ...
|
read more...
|
$1,995.00
|
|
Botswana Pharmaceuticals and Healthcare Report Q2 2013
2/13/2013 | published by: Business Monitor International
... are able to seek medical treatment. However, communication and transport hindrances as well as poor utilisation of existing healthcare services in rural areas means uptake is low. Consequently, it is unlikely Botswana will be of ...
|
read more...
|
$1,175.00
|